Fate of Glenmark's Crofelemer uncertain on legal dispute
PUBLISHED ON: July 28, 2011 | Duration: 2 min, 14 sec
Pharma major Glenmark's drug Crofelemer promises huge opportunities but its marketing partners Napo Pharma and Salix Pharma are embroiled in a legal dispute. This is likely to affect its launch in the market.
